HN2010001700A - Procedimiento de preparacion de combretastatina - Google Patents

Procedimiento de preparacion de combretastatina

Info

Publication number
HN2010001700A
HN2010001700A HN2010001700A HN2010001700A HN2010001700A HN 2010001700 A HN2010001700 A HN 2010001700A HN 2010001700 A HN2010001700 A HN 2010001700A HN 2010001700 A HN2010001700 A HN 2010001700A HN 2010001700 A HN2010001700 A HN 2010001700A
Authority
HN
Honduras
Prior art keywords
formula
salt
base
commbretastatin
combretastatine
Prior art date
Application number
HN2010001700A
Other languages
English (en)
Inventor
Frederic Marc
Lutz Sylviane
Malpart Joel
Masson Philippe
Mutti Stephane
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39816950&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HN2010001700(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of HN2010001700A publication Critical patent/HN2010001700A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • C07C217/82Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring
    • C07C217/84Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings of the same non-condensed six-membered aromatic ring the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00Preparation of carboxylic acid amides
    • C07C231/16Preparation of optical isomers
    • C07C231/18Preparation of optical isomers by stereospecific synthesis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO DE PREPPARACION DE UNA COMBRETASTATINA (A): FORMULA (I) EN FORMA DE BASE O DE UNA SAL DE ADICION CON UN ACIDO, QUE CONSISTE EN ACOPLAR EN PRESENCIA DE UNA BASE Y DE T3P LA SAL DEL COMPUESTO (Z)-AMINO DE FORMULA (II) CON UN DERIVADO DE LA L-SERINA DOBLEMENTE PROTEGIDO DE FORMULA (III) EN LA CUAL PG DESIGNA UN GRUPO PROTECTOR DE LA FUNCION AMINA DE MANERA QUE SE OBTIENE EL COMPUESTO DE FORMULA (Z)-(Ib): FORMULA (IV) LUEGO, EN DESPROTEGER Y ABRIR EL CIELO DE (Z)-(Ib) EN PRESENCIA DE UN ACIDO DE MANERA QUE SE OBTIENE LA COMBRETASTATINA (A) EN FORMA DE SAL; Y, EVENTUALMENTE, EN AÑADIR UNA BASE DE MANERA QUE SE OBTIENE LA COMBRETASTATINA (A) EN FORMA DE BASE, HABIENDO SIDO OBTENIDA LA SAL DEL COMPUESTO (Z)-AMINO MEDIANTE UN ENRIQUECIMIENTO DE LA SAL DEL COMPUESTO AMINO DE FORMULA EN ISOMERO (Z)
HN2010001700A 2008-02-28 2010-08-26 Procedimiento de preparacion de combretastatina HN2010001700A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0801092A FR2928148B1 (fr) 2008-02-28 2008-02-28 Procede de preparation de combretastatine

Publications (1)

Publication Number Publication Date
HN2010001700A true HN2010001700A (es) 2013-06-17

Family

ID=39816950

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2010001700A HN2010001700A (es) 2008-02-28 2010-08-26 Procedimiento de preparacion de combretastatina

Country Status (28)

Country Link
US (1) US20110124899A1 (es)
EP (2) EP2562154A1 (es)
JP (1) JP2011513286A (es)
KR (1) KR20100116644A (es)
CN (1) CN102015620A (es)
AR (1) AR072772A1 (es)
AU (1) AU2009229027A1 (es)
BR (1) BRPI0907999A2 (es)
CA (1) CA2716541A1 (es)
CL (3) CL2009000463A1 (es)
CO (1) CO6241150A2 (es)
CR (1) CR11635A (es)
DO (1) DOP2010000250A (es)
EA (2) EA201300249A1 (es)
EC (1) ECSP10010421A (es)
FR (1) FR2928148B1 (es)
HN (1) HN2010001700A (es)
IL (2) IL207754A0 (es)
MA (1) MA32193B1 (es)
MX (1) MX2010009514A (es)
NI (1) NI201000144A (es)
NZ (1) NZ587505A (es)
PE (1) PE20091559A1 (es)
SG (1) SG183658A1 (es)
TW (1) TW200948753A (es)
UY (1) UY31681A1 (es)
WO (1) WO2009118474A1 (es)
ZA (1) ZA201006137B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2953518B1 (fr) 2009-12-03 2012-01-20 Sanofi Aventis Procede de preparation d'un derive de combretastatine
WO2013084150A1 (en) * 2011-12-06 2013-06-13 Sanofi Novel crystal form of (2s)-2-amino-3-hydroxy-n-[2-methoxy-2-[(1z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide and method of preparation thereof
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104447598B (zh) * 2013-09-18 2017-09-22 浙江大德药业集团有限公司 Ca‑4的大环多胺衍生物及其抗肿瘤特性
CN104817519B (zh) * 2015-05-11 2016-11-16 中国药科大学 一类ca-4的衍生物、其制法及其医药用途
CN104892668B (zh) * 2015-05-12 2017-03-29 上海大学 考布他汀类似物水溶性前‑前药及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1217500A (en) * 1967-05-24 1970-12-31 Ici Ltd Separation of trans-trans enriched salts of 4,4'-diaminodicyclohexylmethane
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
US5731353A (en) 1993-09-08 1998-03-24 Ajinomoto Co., Inc. Stilbene derivatives and pharmaceutical compositions containing them
US5561122A (en) 1994-12-22 1996-10-01 Arizona Board Of Regents Acting On Behalf Of Arizona State University Combretastatin A-4 prodrug
TW334418B (en) * 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
JPH08272028A (ja) * 1995-03-30 1996-10-18 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその製造方法
JP2000239274A (ja) * 1998-12-16 2000-09-05 Nippon Kayaku Co Ltd 新規ナフチリジン誘導体の製造法
ES2281374T3 (es) * 1999-12-21 2007-10-01 Teva Pharmaceutical Industries Ltd. Nuevos polimorfos de hidrocloruro de sertralina, procedimientos para su preparacion, composiciones que los contienen y metodos para su utilizacion.
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US6759555B2 (en) * 2002-04-11 2004-07-06 Aventis Pharma S.A. Process for the preparation of combretastatins
DE10333042B4 (de) * 2003-07-21 2005-09-29 Clariant Gmbh Verfahren zur Herstellung von cyclischen Phosphonsäureanhydriden und deren Verwendung

Also Published As

Publication number Publication date
TW200948753A (en) 2009-12-01
AU2009229027A1 (en) 2009-10-01
AR072772A1 (es) 2010-09-22
ECSP10010421A (es) 2010-09-30
NZ587505A (en) 2012-06-29
CA2716541A1 (fr) 2009-10-01
CN102015620A (zh) 2011-04-13
MX2010009514A (es) 2010-12-15
ZA201006137B (en) 2011-11-30
CR11635A (es) 2011-02-04
CO6241150A2 (es) 2011-01-20
KR20100116644A (ko) 2010-11-01
BRPI0907999A2 (pt) 2019-01-15
FR2928148B1 (fr) 2013-01-18
UY31681A1 (es) 2009-09-30
JP2011513286A (ja) 2011-04-28
EA201071001A1 (ru) 2011-02-28
DOP2010000250A (es) 2010-09-30
WO2009118474A1 (fr) 2009-10-01
PE20091559A1 (es) 2009-10-30
EP2252572A1 (fr) 2010-11-24
WO2009118474A8 (fr) 2010-09-10
FR2928148A1 (fr) 2009-09-04
CL2012001744A1 (es) 2012-10-12
NI201000144A (es) 2011-03-09
EP2562154A1 (fr) 2013-02-27
IL225776A0 (en) 2013-06-27
CL2012001742A1 (es) 2012-11-16
EA201300249A1 (ru) 2013-08-30
SG183658A1 (en) 2012-09-27
CL2009000463A1 (es) 2010-12-03
IL207754A0 (en) 2010-12-30
US20110124899A1 (en) 2011-05-26
MA32193B1 (fr) 2011-04-01

Similar Documents

Publication Publication Date Title
HN2010001700A (es) Procedimiento de preparacion de combretastatina
BR112014009146A2 (pt) formulações de etanercepte estabilizadas com aminoácidos
CR20150663A (es) Derivados de diazacarbazol como ligandos de tau para pet
CR20140134A (es) Composiciones farmacéuticas
NI201100223A (es) Derivados de imidazolidina 2 -0ne 1,3 - disustituidos como inhibidores de cyp 17
CU20120122A7 (es) Derivados 5-aril-1,2,4-triazolona ligada a bisarilo sustituidos
CO6531500A2 (es) Composiciones y metodos para el tratamiento de la xerostomia
RS53868B1 (en) ATP-BINDING CASSETTE TRANSPORT MODULATORS
BRPI1014543B8 (pt) Moléculas e composições pesticidas
CO6390081A2 (es) Compuestos organicos
RS52716B (en) HYDROBENZAMIDE DERIVATIVES AS HEAT SHOCK PROTEIN INHIBITORS HSP90
BR122018074306B8 (pt) Método para preparar um composto de fórmula 1a
BR112012031510A2 (pt) composição farmacêutica compreendendo derivado de amida ou um sal deste farmaceuticamente aceitável
CY1115623T1 (el) Μεθοδος για την συνθεση 7,8-διμεθοξυ-1,3-διϋδρο-2η-3-βενζαζεπιν-2-ονης και εφαρμογη αυτης στη συνθεση της ιβαμπραδινης καθως επισης αλατων προσθηκης αυτης με ενα φαρμακευτικως αποδεκτο οξυ
AR081520A1 (es) Composicion farmaceutica que comprende una dispersion solida de tacrolimus en un vehiculo
BR112014026198A2 (pt) compostos pirazol como inibidores de sglt1
CR20140114A (es) Compuestos de benzotiazolona
UY32075A (es) Estabilización de preparaciones acuosas de minerales mediante reuterina
BR112013028789A2 (pt) processo
BR112014009760A8 (pt) análogos de ácido siálico
BR112015009988A2 (pt) melhoramentos em compostos orgânicos ou relativos
BRPI0814115B8 (pt) composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto
EA201100350A1 (ru) Противогрибковые средства
BR112013011244A2 (pt) processo para a preparação de derivados e ácido 3-(6-amino-piridin-3il)-2-acrílico
CY1116477T1 (el) Μεθοδος εnzυμatiκης συνθεσης toy (7s)-3,4-διμεθοξυδικυκλο[4.2.0] οκτα-1,3,5-τριενo-7-καρβοξυλικου οξεος ή εστερων αυτου και εφαρμογη στην συνθεση της ιβαμπραδινης και των αλατων αυτης